Fenofibrate for Prevention of DR Worsening

Fenofibrate for Prevention of DR Worsening
Condition:   Diabetic Retinopathy
Interventions:   Drug: Fenofibrate;   Other: Placebo
Sponsors:   Jaeb Center for Health Research;   National Institutes of Health (NIH);   National Eye Institute (NEI);   Juvenile Diabetes Research Foundation;   Roche Pharma AG;   The Leona M. and Harry B. Helmsley Charitable Trust

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 30, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine